Covid19 Prevention Completed Phase 3 Trials for Janssen COVID-19 Vaccine (DB15857)

Back to Covid19 Prevention

Also known as: COVID-19 Prevention

IndicationStatusPhase
DBCOND0132125 (Covid19 Prevention)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05091307
A Study of Ad26.COV2.S and Influenza Vaccines in Healthy AdultsPrevention
NCT04908722
A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy AdultsPrevention